|
Mc3 investigated the returned product.That had clotted off and required device exchange.The root cause of low flow performance ot the oxygenator and device change-out is believed to be a blood clot in the fiber bundle created by an upstream circuit source, possibly the pumphead or patient based on the following: customer stated there was an abrupt drop in flow at approximately 6am, 4.5 hours after the start of procedure.According to records, the device performed as expected for 4.5 hours which describes normal function.No observation of clots in circuit prior to 6am.Oxygenator adjustments would have been made if there was an obstruction preventing flow, prior to 6am.The abrupt drop in flow indicates the clot suddenly entered the fiber bundle, inhibiting flow and causing change-out.Customer described that the pumphead " felt hot" which has an unknown impact.The pump was not retained so could not be investigated.An impella device was also used in this patient with unknown impact.This is believed to be an isolated incident with no impact to production or product in the field.
|
|
Distributor received information that during use of a mc3 nautilus oxygenator, there was difficulty maintaining flow above 0.5 l/min.The system/pump/circuit was changed out for cardiohelp.And the flow improved to 3.5-4.0 l/min.It was suspected that the nautilus clotted off.The ap40 centrifugal pump was part of the circuit.Additional information from the sales rep: the patient was on fem -fem va extracorporeal membrane oxygenation (ecmo).The patient had been placed on support on (b)(6) 2020 at 01:29.Rpm: 3070, flow: 4.3l/min new flow with cardiohelp: 4.0l/min, 3665rpm.Cardiac patient placed on fem-fem va ecmo and impella for support.Drainage lt fem ven: 24fr edwards reinfusion lt fem art: 18fr edwards loading dose of heparin was 5,000, no heparin after.Pt: 22, inr: 2.1, aptt: 90.2.An adapter was not used with the ap40, it was mounted directly in the bio-console.
|